Nomed Biotech Private Limited
Nomed Biotech Private Limited is a Private Non-govt company company incorporated in 2022 and based in Rajasthan, India. It was founded by Ram and Sandeep. Nomed Biotech Private Limited operates in Medical & Precision (NIC 33119) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2023-24, the company reported revenue of ₹18.39 L and a net loss of ₹20.6K. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Nomed Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 883231630 | Kotak Mahindra Bank Ltd(Bank) | ₹2.93 Cr | 12 Mar 2019 | Satisfied |
| 665046567 | Axis Bank Ltd(Bank) | ₹1.60 Cr | 27 Jan 2022 | Satisfied |
| 799085424 | HDFC Bank Ltd(Bank) | ₹17.62 Cr | 27 Jan 2019 | Open |
| 686123820 | Kotak Mahindra Bank Ltd(Bank) | ₹14.31 Cr | 27 Jan 2021 | Satisfied |
| 795390709 | State Bank of India(Bank) | ₹14.03 Cr | 27 Jan 2019 | Open |
Charge IDs, lenders & amounts for Nomed Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — |
Detailed Financials
1 FYs| Line item | 2023-24 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹89.44 Cr | +1.0% | -1.8% | +11.4% |
| Profit after Tax | ₹12.47 Cr | +11.4% | +27.3% | +6.4% |
| Net Worth | ₹78.19 Cr | -1.8% | -0.6% | +4.3% |
| Employees | 181 | +6.6% | -2.5% | +12.5% |
Audited financials & ratios for Nomed Biotech Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2023-24 | -1.12% | — | -20.81% | -1.62% | 12.82 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,37,33,998 | 68.77% |
| Institutional Investors | 3 | 23,03,879 | 6.68% |
| Public & Others | 7 | 84,74,193 | 24.55% |
Promoter, institutional & public holding for Nomed Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
15 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.